All Studies

Zingiber officinale ameliorates Alzheimer's disease and Cognitive Impairments: Lessons from preclinical studies.

Alzheimer's disease (AD) is a neurodegenerative condition that causes cognitive impairments. Researchers are searching for new treatments due to the limited efficacy and side effects of current medications. This study evaluated the potential protective properties of the compounds found in ginger against memory impairments. Both in vitro and in vivo studies were conducted, as well as clinical trials. The results demonstrated that ginger and its components have the potential to improve and prevent memory dysfunctions by targeting oxidative stress, neuroinflammation, and apoptosis. However, more studies are required to evaluate their pharmaceutical aspects.

Talebi M et al (2021).
Biomed Pharmacother.
PubMed:
33378982

Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections.

Scientists are searching for new ways to treat coronavirus infections, including COVID-19. They have discovered that the RNA dependent RNA polymerase (RdRp) is effective at targeting the virus. To this end, they have been studying lycorine, a compound found in the bulbs of Lycoris radiata (L'Hér.) Herb, which has antiviral properties. Lycorine has been shown to inhibit the replication of different types of viruses, making it a promising candidate for further research. By developing new treatments that target the RdRp protein, scientists aim to find a highly effective treatment against emerging coronavirus infections.

Jin YH et al (2021).
Phytomedicine.
PubMed:
33376043